NO842572L - Fremgangsmaate for fremstilling av humantumornekrosefaktor og humaniterferon med virkning paa human-kreftceller - Google Patents

Fremgangsmaate for fremstilling av humantumornekrosefaktor og humaniterferon med virkning paa human-kreftceller

Info

Publication number
NO842572L
NO842572L NO842572A NO842572A NO842572L NO 842572 L NO842572 L NO 842572L NO 842572 A NO842572 A NO 842572A NO 842572 A NO842572 A NO 842572A NO 842572 L NO842572 L NO 842572L
Authority
NO
Norway
Prior art keywords
htnf
cells
hlfn
produced
cell
Prior art date
Application number
NO842572A
Other languages
English (en)
Norwegian (no)
Inventor
Lloyd J Old
Elizabeth Carswell Richards
Berish Y Rubin
Barbara D Williamson
Jay S Prendergast
Original Assignee
Sloan Kettering Inst Cancer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sloan Kettering Inst Cancer filed Critical Sloan Kettering Inst Cancer
Publication of NO842572L publication Critical patent/NO842572L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/525—Tumour necrosis factor [TNF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
NO842572A 1983-06-27 1984-06-26 Fremgangsmaate for fremstilling av humantumornekrosefaktor og humaniterferon med virkning paa human-kreftceller NO842572L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US50847283A 1983-06-27 1983-06-27

Publications (1)

Publication Number Publication Date
NO842572L true NO842572L (no) 1984-12-28

Family

ID=24022900

Family Applications (1)

Application Number Title Priority Date Filing Date
NO842572A NO842572L (no) 1983-06-27 1984-06-26 Fremgangsmaate for fremstilling av humantumornekrosefaktor og humaniterferon med virkning paa human-kreftceller

Country Status (15)

Country Link
EP (1) EP0131789A3 (enEXAMPLES)
JP (1) JPS6036420A (enEXAMPLES)
KR (1) KR850000528A (enEXAMPLES)
AU (1) AU587959B2 (enEXAMPLES)
CA (1) CA1265444A (enEXAMPLES)
DD (3) DD229713A5 (enEXAMPLES)
DK (1) DK311984A (enEXAMPLES)
ES (2) ES8603949A1 (enEXAMPLES)
FI (1) FI842560A7 (enEXAMPLES)
GR (1) GR82260B (enEXAMPLES)
HU (2) HU197358B (enEXAMPLES)
NO (1) NO842572L (enEXAMPLES)
NZ (1) NZ208648A (enEXAMPLES)
PT (1) PT78773B (enEXAMPLES)
ZA (1) ZA844377B (enEXAMPLES)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4920196A (en) * 1982-07-30 1990-04-24 Genentech, Inc. Human lymphotoxin
JPS59141519A (ja) * 1983-01-31 1984-08-14 Otsuka Pharmaceut Co Ltd 制ガン作用を有する蛋白質
US5288852A (en) * 1984-03-06 1994-02-22 Dainippon Pharmaceutical Co., Ltd. Human tumor necrosis factor polypeptides
US4879226A (en) * 1984-04-06 1989-11-07 Asahi Kasei Kogyo Kabushiki Kaisha Novel human physiologically active polypeptide
JPS60243018A (ja) * 1984-05-17 1985-12-03 Yamanouchi Pharmaceut Co Ltd ヒト内来性癌制御因子
DE3423234A1 (de) * 1984-06-23 1986-02-06 Boehringer Ingelheim International GmbH, 6507 Ingelheim Synergistische mischungen von interferonen und tumor-nekrose-faktor
US5672347A (en) * 1984-07-05 1997-09-30 Genentech, Inc. Tumor necrosis factor antagonists and their use
GR851626B (enEXAMPLES) * 1984-07-05 1985-11-26 Genentech Inc
US6686455B1 (en) 1984-07-05 2004-02-03 Genentech, Inc. Tumor necrosis factor
US4650674A (en) * 1984-07-05 1987-03-17 Genentech, Inc. Synergistic cytotoxic composition
IL76591A0 (en) * 1984-10-05 1986-02-28 Bioferon Biochem Substanz Pharmaceutical compositions containing ifn-ypsilon and processes for the preparation thereof
JP2675294B2 (ja) * 1984-10-15 1997-11-12 カイロン コーポレイション ヒト腫瘍壊死因子
US4959314A (en) 1984-11-09 1990-09-25 Cetus Corporation Cysteine-depleted muteins of biologically active proteins
AU601675B2 (en) * 1984-12-21 1990-09-20 Biogen, Inc. Purification, production and use of tumor necrosis factors
EP0205038A1 (en) * 1985-05-29 1986-12-17 Suntory Limited Polypeptide, process for preparing it, microorganism and pharmaceutical use
US4894439A (en) * 1986-05-22 1990-01-16 Cetus Corporation N-terminal derivatives of tumor necrosis factor purified by microporous PTFE membranes
US4677197A (en) * 1985-10-30 1987-06-30 Cetus Corporation Purification method for tumor necrosis factor
NZ219027A (en) * 1986-01-24 1989-09-27 Genentech Inc Antiviral composition containing interferon tumour necrosis factor and/or lymphotoxin
US4828830A (en) * 1986-01-24 1989-05-09 Genentech, Inc. Method and composition for prophylaxis and treatment of viral infections
CA1290249C (en) * 1986-04-09 1991-10-08 Cetus Corporation COMBINATION THERAPY USING INTERLEUKIN-2 AND/OR INTERFERON-.beta. AND TUMOR NECROSIS FACTOR
US5425940A (en) * 1986-04-09 1995-06-20 Cetus Oncology Corporation Combination therapy using interleukin-2 and tumor necrosis factor
US4863727A (en) * 1986-04-09 1989-09-05 Cetus Corporation Combination therapy using interleukin-2 and tumor necrosis factor
IL80005A (en) * 1986-09-10 1992-11-15 Yeda Res & Dev Compositions for modulating the effect of tnf and il-1
US4894225A (en) * 1987-03-02 1990-01-16 Cetus Corporation Combination therapy using antitumor immunotoxins with tumor necrosis factor
DE102012024749A1 (de) * 2012-12-11 2014-06-26 Martin Röcken Tumorprävention und -therapie durch Induktion einer Tumorseneszenz

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2513124B1 (fr) * 1981-07-21 1989-11-17 Hayashibara Biochem Lab Production et applications du facteur de lyse des cellules-cibles
JPH0695939B2 (ja) * 1983-12-02 1994-11-30 大日本製薬株式会社 ウサギ癌壊死因子をコ−ドするクロ−ン化ｄνａ
GR851626B (enEXAMPLES) * 1984-07-05 1985-11-26 Genentech Inc

Also Published As

Publication number Publication date
DK311984A (da) 1984-12-28
KR850000528A (ko) 1985-02-27
ZA844377B (en) 1985-05-29
DD241268A5 (de) 1986-12-03
ES533767A0 (es) 1986-01-01
ES8603949A1 (es) 1986-01-01
DK311984D0 (da) 1984-06-26
EP0131789A3 (en) 1986-12-03
PT78773B (en) 1986-06-26
NZ208648A (en) 1989-07-27
HUT34775A (en) 1985-04-28
JPS6036420A (ja) 1985-02-25
AU2933784A (en) 1985-01-03
PT78773A (en) 1984-07-01
ES545258A0 (es) 1986-07-16
AU587959B2 (en) 1989-09-07
HU201680B (en) 1990-12-28
HU197358B (en) 1989-03-28
DD229713A5 (de) 1985-11-13
ES8608885A1 (es) 1986-07-16
FI842560L (fi) 1984-12-28
EP0131789A2 (en) 1985-01-23
CA1265444A (en) 1990-02-06
DD241271A5 (de) 1986-12-03
GR82260B (enEXAMPLES) 1984-12-13
FI842560A0 (fi) 1984-06-26
FI842560A7 (fi) 1984-12-28

Similar Documents

Publication Publication Date Title
NO842572L (no) Fremgangsmaate for fremstilling av humantumornekrosefaktor og humaniterferon med virkning paa human-kreftceller
JP3825467B2 (ja) インターロイキン―７を用いた選定免疫療法
Luettig et al. Macrophage activation by the polysaccharide arabinogalactan isolated from plant cell cultures of Echinacea purpurea
Wherry et al. Regulation of gamma interferon production by natural killer cells in scid mice: roles of tumor necrosis factor and bacterial stimuli
Titus et al. Intracellular destruction of Leishmania tropica by macrophages activated with macrophage activating factor/interferon
JPH04506006A (ja) ヒトサイトカイン、インターロイキン―９
US4785077A (en) Substantially pure cytotoxicity triggering factor
JPH10510147A (ja) 二次性免疫不全症の治療用薬剤の製造方法
JP2846629B2 (ja) 組換えコロニー刺激因子−１を含んで成る医薬組成物
Van Pham et al. Metabolic and functional stimulation of lymphocytes and macrophages by an Escherichia coli extract (OM-89): in vitro studies
Reed et al. Immune deficiency in chronic Trypanosoma cruzi infection. Recombinant IL-1 restores Th function for antibody production.
Klein et al. Modulation of murine immune cell function by marijuana components
Shalit et al. Enhanced hematopoiesis in sublethally irradiated mice treated with various quinolones
US5681557A (en) Use of interleukin-7 to induce monocytes/macrophages cytotoxic activity
Pezzella et al. In vivo inhibition of tumor growth of B16 melanoma by recombinant interleukin 1β: I. Tumor inhibition parallels lymphocyte-activating factor activity of interleukin 1β proteins
Richard et al. Cytokines involved in the augmentation of murine natural killer cell activity by pyrimidinones in vivo
Rowland et al. Nitric oxide production by splenic macrophages is not responsible for T cell suppression during acute infection with lactate dehydrogenase-elevating virus.
US7776818B2 (en) Methods to treat T-cell disorders using TISF
AU643245B2 (en) A pharmaceutical preparation for the maturation of prothymocytes
Hirayama et al. Accessory cell functions of dendritic cells and macrophages in the thymic T-cell response to Con A
Wing et al. Analysis of colony-stimulating factors and macrophage progenitor cells in mice immunized against Listeria monocytogenes by adoptive transfer
Ohta et al. Thymosin-α1 Increases the Capability to Produce Interleukin-3 but Not Interleukin-2 in nu/nu Mice
Moudgil Immunosuppression in the postoperative period
McKinnon et al. Cytolysis of Actinomycin D-treated target cells by cell-free supernatants from human monocytes
Igarashi et al. Induction of the differentiation of memory T killer cells with factors released from macrophage-like cell lines